J G F Bronzwaer
Overview
Explore the profile of J G F Bronzwaer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
89
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Aengevaeren W, Laarman G, Suttorp M, Ten Berg J, van Boven A, de Boer M, et al.
Neth Heart J
. 2015 Feb;
13(11):416-422.
PMID: 25696433
Interventional cardiology is an expanding field within cardiovascular medicine and today it is generally accepted that cardiologists require specific training, knowledge and skills. Hospitals where coronary interventions are performed must...
2.
Gan C, Vonk Noordegraaf A, Marques K, Bronzwaer J, Postmus P, Boonstra A
Neth Heart J
. 2015 Feb;
12(7-8):337-342.
PMID: 25696358
Medical therapy for pulmonary arterial hypertension (PAH) focuses on pulmonary vascular remodelling and smooth muscle cell proliferation. This article covers the drugs which are approved or are in sight and...
3.
Gan C, Vonk Noordegraaf A, Marques K, Bronzwaer J, Postmus P, Boonstra A
Neth Heart J
. 2015 Feb;
12(6):287-294.
PMID: 25696347
Pulmonary arterial hypertension (PAH) is a disease characterised by an increased pulmonary artery pressure. The precapillary pulmonary arteries show distinct pathobiological changes, i.e. medial hypertrophy, intimal fibrosis, microthrombi and plexiform...
4.
Oud N, Marques K, Bronzwaer J, Brinckman S, Allaart C, de Cock C, et al.
Neth Heart J
. 2010 Sep;
18(9):402-7.
PMID: 20862234
Objectives. The aim of this study was to analyse the rate of major adverse clinical events in patients with coronary artery disease and a fractional flow reserve (FFR) of ≥0.75...
5.
Overbeek M, Lankhaar J, Westerhof N, Voskuyl A, Boonstra A, Bronzwaer J, et al.
Eur Respir J
. 2008 Jan;
31(6):1160-6.
PMID: 18216049
Since systemic sclerosis (SSc) also involves the heart, the aim of the present study was to evaluate possible differences in right ventricular (RV) pump function between SSc-associated pulmonary arterial hypertension...
6.
Bruynzeel A, Niessen H, Bronzwaer J, van der Hoeven J, Berkhof J, Bast A, et al.
Br J Cancer
. 2007 Oct;
97(8):1084-9.
PMID: 17940501
The purpose of this study was to investigate the cardioprotective effect of the semisynthetic flavonoid 7-monohydroxyethylrutoside (monoHER) on doxorubicin (DOX)-induced cardiotoxicity in a phase II study in patients with metastatic...
7.
van Wolferen S, Boonstra A, Marcus J, Marques K, Bronzwaer J, Postmus P, et al.
Heart
. 2006 Nov;
92(12):1860-1.
PMID: 17105892
No abstract available.
8.
Smit H, Vonk Noordegraaf A, Roeleveld R, Bronzwaer J, Postmus P, de Vries P, et al.
Physiol Meas
. 2002 Mar;
23(1):237-43.
PMID: 11878269
Electrical impedance tomography (EIT) has been proposed as a method to monitor dynamic changes in the pulmonary vascular bed. In this study we examined the validity of EIT in the...